Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Enzon Pharmaceuticals Inc (ENZN)

Enzon Pharmaceuticals Inc (ENZN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0991 +0.0045 (+4.76%) 04/17/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0991 unch (unch) 14:21 ET
Profile for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Enzon Pharmaceuticals Inc 20 Commerce Drive Suite 135 Cranford NJ 07016 USA

www.enzon.com P: 732-980-4500

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Enzon Pharmaceuticals, Inc. is a biotechnology company. It discovers, develops, and commercializes therapeutics to treat life-threatening diseases. The Company's marketed drug products include PegIntron (R) for chronic hepatitis C; Sylatron (R) for Melanoma; Macugen (R) for neovascular age-related macular degeneration; CIMZIA (R) for Crohn's disease; Oncaspar for acute lymphoblastic leukemia; and Adagen for severe combined immunedeficiency. Enzon Pharmaceuticals, Inc. is headquartered in Piscataway, New Jersey.

Key Statistics

Overview:

Market Capitalization, $K 7,021
Enterprise Value, $K 2,641
Shares Outstanding, K 74,215
Annual Sales, $ 30 K
Annual Net Income, $ 780 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ 250 K
EBIT, $ -1,230 K
EBITDA, $ -1,230 K
60-Month Beta 0.23
% of Insider Shareholders 0.40%
% of Institutional Shareholders 0.00%
Float, K 73,918
% Float 99.60%
Short Volume Ratio 0.92

Growth:

1-Year Return 36.88%
3-Year Return -72.16%
5-Year Return -38.33%
5-Year Revenue Growth -85.71%
5-Year Earnings Growth 50.00%
5-Year Dividend Growth -100.00%

Per-Share Information:

Most Recent Earnings 0.00 on 02/21/25
Next Earnings Date 05/09/25 [--]
Earnings Per Share ttm 0.01
EPS Growth vs. Prev Year -100.00%
Annual Dividend Yield 0.00%
Most Recent Dividend 0.240 on 09/30/19
Next Ex-Dividends Date 09/30/19
Dividend Payable Date 10/15/19
Dividend Payout Ratio 0.00%

ENZN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 25.71%
Return-on-Assets % 1.65%
Profit Margin % 2,600.00%
Debt/Equity 0.00
Price/Sales 280.30
Price/Cash Flow 9.02
Price/Book 2.33
Book Value/Share 0.63
Interest Coverage -1.84
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro